- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07802067
Skills Training and Relief for Orofacial Pain (STAR)
SKILLS TRAINING AND RELIEF FOR OROFACIAL PAIN: FEASIBILITY AND ACCEPTABILITY OF A SINGLE SESSION PAIN MANAGEMENT COURSE IN A TERTIARY OROFACIAL PAIN CLINIC
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Chronic orofacial pain (COFP) is comprised of various disorders in the temporomandibular region causing pain that lasts more than three months and are associated with substantial physical and psychological burden. These disorders often co-occur with other conditions such as headache, general chronic pain, and psychiatric disorders (e.g, anxiety and depression; Hernández-Nuño de la Rosa et al., 2023). The etiology of COFP is complex, with environmental, psychosocial, emotional, and genetic factors contributing to the development, chronicity, and maintenance of these disorders (Hernández-Nuño de la Rosa et al., 2023). Regardless of etiology, COFPs are impactful, commonly resulting in interference with daily activities, reduced quality of life (QoL), and mental health difficulties (Miller et al., 2026). COFP disorders are therefore best treated with multidisciplinary approaches combining psychological interventions and comprehensive orofacial pain care.
Numerous psychological interventions for chronic pain are available, drawing from numerous theoretical orientations. Cognitive behavioral therapy (CBT) is a goal focused intervention designed to teach patients skills in restructuring cognitive distortions and thought patterns while promoting self-efficacy, which have shown to reduce pain intensity and psychological distress (Miller et al., 2026; Nagi et al., 2025; Tan et al., 2017; Carlson, 2008). Many relaxation techniques use a self-management approach by encouraging patients' role in managing their condition by learning skills to implement within their daily routine (Aggarwal et al., 2019; Nicholas & Blyth, 2016). Carlson (2008) categorizes multiple methods of relaxation techniques ranging from brief, easily taught skills to structured therapist-led interventions. He categorizes multiple methods of relaxation techniques ranging from brief, easily taught skills (brief relaxation techniques) to structured therapist-led interventions such as Physical Self-Regulation, where a therapist trains the patient through breathing exercises, clenching awareness, postural relaxation, and postural reeducation (progressive relaxation training) (Carlson, 2008).
Despite the multitude of empirically-supported psychological interventions available, they all share common obstacles; namely, that uptake of these interventions in COFP clinic is low due to lack of sufficient specialized orofacial pain treatment providers, financial resources, and mental health stigma, and patients not expecting to have clinical psychologists involved in their COFP management, which has historically been treated (with minimal success) by dental providers alone, among other obstacles. Additionally, while literature suggests the effectiveness of these interventions for COFP populations, patients are often met with access related issues. These treatments introduce barriers through financial costs associated with healthcare and travel, lack of geographic access, especially for patients in rural communities, and few professionally certified clinicians to provide services (Melanie et al., 2026: Ziadni et al., 2021). Consequently, there is also a lack of multimodal tertiary clinics available that offer treatments combining dental, psychological, and behavioral healthcare, leading patients to travel far distances for interdisciplinary treatments that can last hours across multiple sessions (Lagisetty et al., 2021). Geographic access also poses a significant issue because interdisciplinary COFP clinics are scarce, with many states not having any access to specialty care, despite their being empirical evidence for greater longitudinal outcomes in COFP patients (Miller et al., 2026; Esposito et al., 2026).
Recent literature has identified Empowered Relief (ER), a virtual single-session, two-hour group-based intervention developed at Stanford University that overcomes many of the existing obstacles. ER introduces evidenced-based skills through a single session, two-hour course where patients develop tools that allow them to become self-sufficient in managing their chronic pain. The session can be held through a virtual format, providing accessible care and reducing patient travel or long stays. The training also provides space for multiple patients to receive care at one time as ER is hosted in a group format, allowing more patients to receive treatment over time.
The effectiveness of ER was first demonstrated through a pilot study that included participants with various chronic pain conditions which indicated significant reduction in distress and improved participants' ability to use self-regulation strategies for pain management 4 weeks post intervention (Ziadni et al., 2021). Additionally, a randomized control study found that one session of ER was just as effective as eight weeks of traditional CBT for reducing pain catastrophizing and pain intensity in individuals with chronic lower back pain (Ziadni et al., 2021). Currently, no literature to date has investigated the feasibility and acceptability of ER in patients with COFP, indicating a gap in literature. The present study aims to fill this gap to work towards the identification of a low-cost and low-burden intervention for this underserved population.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Kathleen E Wakeman, M.S.
- Phone Number: 508-759-8037
- Email: kewa246@uky.edu
Study Locations
-
-
Kentucky
-
Lexington, Kentucky, United States, 40509
- University of Kentucky
-
Contact:
- Ian Boggero, PhD
- Phone Number: 859-562-3291
- Email: ian.boggero@uky.edu
-
Contact:
- Kathleen E Wakeman, M.S.
- Phone Number: 5027598037
- Email: kewa246@uky.edu
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Must be 18 years or older; have the ability to read, write, and speak English; have experienced pain longer than 3 months; be a treatment-seeking patient at the University of Kentucky Orofacial Pain Clinic (UKOPC), and have the technological ability to participate in telehealth treatment in Kentucky (e.g., technology, connection, earbuds or headphones, private space in Kentucky).
Exclusion Criteria:
- Because the UKOPC is a training clinic, participants will be excluded if they report current or recent suicidal or homicidal ideation or intent in the last 2 weeks and/or symptoms of mania, hypomania, or psychosis in the past 6 months.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Immediate Intervention
Participants in this arm will be scheduled to partake in the next available Empowered Relief course
|
Empowered Relief (ER) is a single-session, 2-hour pain management course designed with the purpose of assisting individuals with chronic pain to gain skills for self-pain management.
ER is taught through a PowerPoint presentation which includes pain education, self-regulatory skills (i.e., relaxation, cognitive reframing, and self-soothing), and mindfulness skills, all grounded in pain-CBT theory (Darnall et al., 2021).
The intervention will be delivered by a certified Empowered Relief instructor.
|
|
No Intervention: Waitlist Control
Participants in this arm will be scheduled to partake in the Empowered Relief course approximately 1 month after they consent for the study
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Recruitment Rate
Time Frame: Baseline (week 0)
|
The number of patients who are consented into the study from the UK Orofacial Pain Clinic per month
|
Baseline (week 0)
|
|
Retention Rate
Time Frame: Follow up outcome survey at one month (approximately)
|
The number of patients who were consented into the study and completed the one month follow-up outcome survey
|
Follow up outcome survey at one month (approximately)
|
|
Client Satisfaction
Time Frame: Immediate Intervention - approximately one week after consent and directly after pain management intervention attendance. Waitlist Control - approximately one month after consent and directly after pain management intervention attendance.
|
Client Satisfaction Questionnaire (CSQ) 8 items on a 4 point likert scale.
Higher scores on items 1, 3, 6, 7, likert scale equate to greater satisfaction.
Higher scores on items 2, 4, 5, and 8 likert scale equate to lower satisfaction.
|
Immediate Intervention - approximately one week after consent and directly after pain management intervention attendance. Waitlist Control - approximately one month after consent and directly after pain management intervention attendance.
|
|
Empowered Relief Post Course Survey
Time Frame: Immediate Intervention - approximately one week after consent and directly after pain management intervention attendance. Waitlist Control - approximately one month after consent and directly after pain management intervention attendance.
|
Empowered Relief Post-Course Survey 5 items on a 6 point Likert scale.
Higher scores equate to greater satisfaction with Empowered Relief course, content, and practice.
|
Immediate Intervention - approximately one week after consent and directly after pain management intervention attendance. Waitlist Control - approximately one month after consent and directly after pain management intervention attendance.
|
|
Satisfaction with Class
Time Frame: Immediate Intervention - approximately one week after consent and directly after pain management intervention attendance. Waitlist Control - approximately one month after consent and directly after pain management intervention attendance.
|
Satisfaction with Class (Empowered Relief) is a 11 item survey.
Items 1 - 5 are on a 0 to 10 numeric scale with higher scores equating to greater satisfaction.
Items 6 - 10 are on a 7 point Likert scale with higher scores equating to greater satisfaction.
Item 11 is a closed-ended single select question which includes three answer options.
|
Immediate Intervention - approximately one week after consent and directly after pain management intervention attendance. Waitlist Control - approximately one month after consent and directly after pain management intervention attendance.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
PTSD Symptoms
Time Frame: Baseline (Week 0)
|
The PTSD Symptom Checklist (Past Month) (PCL-5) will assess if the participant has experienced a traumatic event as defined by the DSM-5-TR and if they have experienced PTSD symptoms in the past month related to the event.
The PCL-5 is a 20 item questionnaire with each item rated on a 5-point likert scale ranging from 0 - 4. Higher scores equate to greater intensity and interference of PTSD symptoms.
|
Baseline (Week 0)
|
|
Headache Impact
Time Frame: Baseline (Week 0), Two Week Follow Up (Week 2), One Month Follow up (Week 4)
|
The Headache Impact Test (HIT-6) 6 item questionnaire evaluates pain intensity, life interference, and psychological distress due to headaches.
Items are rated on a 5 point likert scale.
Higher scores equate greater headache impact.
|
Baseline (Week 0), Two Week Follow Up (Week 2), One Month Follow up (Week 4)
|
|
PTSD Symptoms (Past Two Weeks)
Time Frame: Two Week Follow up (Week 2), One Month Follow up (Week 4)
|
The PTSD Short Form (PCL-5-SF) are administered to participants who indicate having experienced a trauma.
The PCL-5-SF is a 4 item questionnaire on a 5 point likert scale.
Higher scores equate to greater PTSD symptoms.
|
Two Week Follow up (Week 2), One Month Follow up (Week 4)
|
|
Pain Self Efficacy
Time Frame: Baseline (Week 0), Two Week Follow Up (Week 2), One Month Follow Up (Week 4)
|
The Pain Self-Efficacy Questionnaire (PSEQ-2) includes two items with a 6 point likert scale.
Lower scores equate to less pain self-efficacy.
|
Baseline (Week 0), Two Week Follow Up (Week 2), One Month Follow Up (Week 4)
|
|
Pain Catastrophizing
Time Frame: Baseline (Week 0), Two Week Follow Up (Week 2), One Month Follow Up (Week 4)
|
The University of Washington Concerns About Pain Scale (UW-CAP-6) evaluates participants pain catastrophizing and negative thoughts in regard to their chronic pain.
UW-CAP-6 short form includes 6 items rated on a 5 point likert scale with higher scores equating to greater levels of pain catastrophizing.
|
Baseline (Week 0), Two Week Follow Up (Week 2), One Month Follow Up (Week 4)
|
|
Acceptance of Chronic Pain
Time Frame: Baseline (Week 0), Two Week Follow Up (Week 2), One Month Follow Up (Week 4)
|
The Chronic Pain Acceptance Questionnaire (CPAQ-8) is an 8 item questionnaire that evaluates participants acceptance of their chronic pain condition.
Items are rated on a 7 point likert scale with higher scores equating to greater pain acceptance.
|
Baseline (Week 0), Two Week Follow Up (Week 2), One Month Follow Up (Week 4)
|
|
Pain Interference
Time Frame: Baseline (Week 0), Two Week Follow Up (Week 2), One Month Follow-Up (Week 4)
|
The PROMIS Pain Interference Short Form (PROMIS 4a) evaluates how much pain interferes with their daily life.
The PROMIS 4a includes 4 items rated on a 5 point likert scale with higher scores equating to pain having greater interference on their life.
|
Baseline (Week 0), Two Week Follow Up (Week 2), One Month Follow-Up (Week 4)
|
|
Anxiety and Depression
Time Frame: Baseline (Week 0), Two Week Follow Up (Week 2), One Month Follow-Up (Week 4)
|
The Patient Health Questionnaire (PHQ-4) is a brief questionnaire evaluating the participants anxiety and depression with 4 items rated on a 4 point likert scale with higher scores equating to greater levels of distress.
|
Baseline (Week 0), Two Week Follow Up (Week 2), One Month Follow-Up (Week 4)
|
|
Fatigue
Time Frame: Baseline (Week 0), Two Week Follow Up (Week 2), One Month Follow-Up (Week 4)
|
The PROMIS-FAT-4 is a brief questionnaire that evaluates participants level and impact of fatigue with 4 items on a 5 point likert scale with higher scores equating to greater severity of fatigue.
|
Baseline (Week 0), Two Week Follow Up (Week 2), One Month Follow-Up (Week 4)
|
|
Satisfaction with Life
Time Frame: Baseline (Week 0), Two Week Follow Up (Week 2), One Month Follow-Up (Week 4)
|
The Satisfaction with Life Scale (SWLS) evaluates participants judgement of satisfaction with the conditions of their life with 5 items rated on a 7 point likert scale with higher scores equating to greater satisfaction with their life's conditions.
|
Baseline (Week 0), Two Week Follow Up (Week 2), One Month Follow-Up (Week 4)
|
|
Jaw Function
Time Frame: Baseline (Week 0), Two Week Follow Up (Week 2), One Month Follow-Up (Week 4)
|
The Jaw Functional Limitation Scale (JFLS) short form evaluates participants jaw function limitations with 8 items on an 11 point numeric scale with higher scores equating to greater jaw function limitation.
|
Baseline (Week 0), Two Week Follow Up (Week 2), One Month Follow-Up (Week 4)
|
|
Insomnia Severity
Time Frame: Baseline (Week 0), Two Week Follow Up (Week 2), One Month Follow-Up (Week 4)
|
The Insomnia Severity Index (ISI-brief) evaluates the participants experience with sleep and the the severity and impact of insomnia if present.
The brief ISI measure includes 7 items on a 5 point likert scale with higher scores equating to greater impact and severity of insomnia symptoms.
|
Baseline (Week 0), Two Week Follow Up (Week 2), One Month Follow-Up (Week 4)
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Kathleen E Wakeman, M.S., University of Kentucky
- Study Chair: Ian Boggero, PhD, University of Kentucky
Publications and helpful links
General Publications
- Larsen DL, Attkisson CC, Hargreaves WA, Nguyen TD. Assessment of client/patient satisfaction: development of a general scale. Eval Program Plann. 1979;2(3):197-207. doi: 10.1016/0149-7189(79)90094-6. No abstract available.
- Diener E, Emmons RA, Larsen RJ, Griffin S. The Satisfaction With Life Scale. J Pers Assess. 1985 Feb;49(1):71-5. doi: 10.1207/s15327752jpa4901_13.
- Attkisson CC, Zwick R. The client satisfaction questionnaire. Psychometric properties and correlations with service utilization and psychotherapy outcome. Eval Program Plann. 1982;5(3):233-7. doi: 10.1016/0149-7189(82)90074-x.
- Morin CM, Belleville G, Belanger L, Ivers H. The Insomnia Severity Index: psychometric indicators to detect insomnia cases and evaluate treatment response. Sleep. 2011 May 1;34(5):601-8. doi: 10.1093/sleep/34.5.601.
- Ohrbach R, Larsson P, List T. The jaw functional limitation scale: development, reliability, and validity of 8-item and 20-item versions. J Orofac Pain. 2008 Summer;22(3):219-30.
- Fish RA, McGuire B, Hogan M, Morrison TG, Stewart I. Validation of the chronic pain acceptance questionnaire (CPAQ) in an Internet sample and development and preliminary validation of the CPAQ-8. Pain. 2010 Jun;149(3):435-443. doi: 10.1016/j.pain.2009.12.016. Epub 2010 Feb 25.
- Houts CR, McGinley JS, Wirth RJ, Cady R, Lipton RB. Reliability and validity of the 6-item Headache Impact Test in chronic migraine from the PROMISE-2 study. Qual Life Res. 2021 Mar;30(3):931-943. doi: 10.1007/s11136-020-02668-2. Epub 2020 Oct 20.
- Nicholas MK, McGuire BE, Asghari A. A 2-item short form of the Pain Self-efficacy Questionnaire: development and psychometric evaluation of PSEQ-2. J Pain. 2015 Feb;16(2):153-63. doi: 10.1016/j.jpain.2014.11.002. Epub 2014 Nov 14.
- Bingham Iii CO, Gutierrez AK, Butanis A, Bykerk VP, Curtis JR, Leong A, Lyddiatt A, Nowell WB, Orbai AM, Bartlett SJ. PROMIS Fatigue short forms are reliable and valid in adults with rheumatoid arthritis. J Patient Rep Outcomes. 2019 Feb 21;3(1):14. doi: 10.1186/s41687-019-0105-6.
- Horowitz LM, Snyder DJ, Boudreaux ED, He JP, Harrington CJ, Cai J, Claassen CA, Salhany JE, Dao T, Chaves JF, Jobes DA, Merikangas KR, Bridge JA, Pao M. Validation of the Ask Suicide-Screening Questions for Adult Medical Inpatients: A Brief Tool for All Ages. Psychosomatics. 2020 Nov-Dec;61(6):713-722. doi: 10.1016/j.psym.2020.04.008. Epub 2020 Apr 28.
- Schrepf A, Maixner W, Fillingim R, Veasley C, Ohrbach R, Smith S, Williams DA. The Chronic Overlapping Pain Condition Screener. J Pain. 2024 Jan;25(1):265-272. doi: 10.1016/j.jpain.2023.08.009. Epub 2023 Aug 24.
- Zuromski KL, Ustun B, Hwang I, Keane TM, Marx BP, Stein MB, Ursano RJ, Kessler RC. Developing an optimal short-form of the PTSD Checklist for DSM-5 (PCL-5). Depress Anxiety. 2019 Sep;36(9):790-800. doi: 10.1002/da.22942. Epub 2019 Jul 29.
- Caro-Fuentes S, Sanabria-Mazo JP. A Systematic Review of the Psychometric Properties of the Patient Health Questionnaire-4 in Clinical and Nonclinical Populations. J Acad Consult Liaison Psychiatry. 2024 Mar-Apr;65(2):178-194. doi: 10.1016/j.jaclp.2023.11.685. Epub 2023 Nov 25.
- Stephan A, Stadelmann VA, Leunig M, Impellizzeri FM. Measurement properties of PROMIS short forms for pain and function in total hip arthroplasty patients. J Patient Rep Outcomes. 2021 May 30;5(1):41. doi: 10.1186/s41687-021-00313-1.
- Amtmann D, Bamer AM, Liljenquist KS, Cowan P, Salem R, Turk DC, Jensen MP. The Concerns About Pain (CAP) Scale: A Patient-Reported Outcome Measure of Pain Catastrophizing. J Pain. 2020 Nov-Dec;21(11-12):1198-1211. doi: 10.1016/j.jpain.2020.03.004. Epub 2020 Jun 13.
- Forkus SR, Raudales AM, Rafiuddin HS, Weiss NH, Messman BA, Contractor AA. The Posttraumatic Stress Disorder (PTSD) Checklist for DSM-5: A Systematic Review of Existing Psychometric Evidence. Clin Psychol (New York). 2023 Mar;30(1):110-121. doi: 10.1037/cps0000111. Epub 2022 Sep 8.
- Cerimele JM, Russo J, Bauer AM, Hawrilenko M, Pyne JM, Dalack GW, Kroenke K, Unutzer J, Fortney JC. The Patient Mania Questionnaire (PMQ-9): a Brief Scale for Assessing and Monitoring Manic Symptoms. J Gen Intern Med. 2022 May;37(7):1680-1687. doi: 10.1007/s11606-021-06947-7. Epub 2021 Jun 18.
- Calkins ME, Ered A, Moore TM, White LK, Taylor J, Moxam AB, Ruparel K, Wolf DH, Satterthwaite TD, Kohler CG, Gur RC, Gur RE. Development and Validation of a Brief Age-Normed Screening Tool for Subthreshold Psychosis Symptoms in Youth. Schizophr Bull. 2025 Sep 8;51(5):1242-1253. doi: 10.1093/schbul/sbae224.
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 119306
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.